A detailed history of High Point Advisor Group LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, High Point Advisor Group LLC holds 3,637 shares of EXAS stock, worth $205,490. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,637
Holding current value
$205,490
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$42.43 - $70.83 $154,317 - $257,608
3,637 New
3,637 $247,000
Q3 2019

Nov 12, 2019

SELL
$90.37 - $122.49 $83,953 - $113,793
-929 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$89.51 - $118.04 $83,154 - $109,659
929 New
929 $107,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.